ICI PAKISTAN PHARMA

ICI PAKISTAN PHARMA

ICI Pakistan Limited takes immense pride in manufacturing, marketing & distributing some of the leading pharmaceutical products available today, including drugs that fight life-threatening diseases. Our strong portfolio of prominent and innovative prescription medicines includes products from internationally renowned pharmaceutical and healthcare partners such as AstraZeneca and Ferrer. We also market our brands; our production capability allows us to manufacture our own high-quality pharmaceuticals and nutraceuticals.

ICI Pharmaceuticals is transforming to become a customer-centric business to foster a positive customer experience at every stage of its decision journey. The marketing strategy has been built on three foundational pillars: Patient/Community Awareness, Advocacy Mobilization, and Scientific Cascades. The focus is on building relationships and delivering value as, when, and how the customer wants it. The business’s journey to move from a single to multichannel approach is another step in this direction.

ICIP Portfolio

Specialty Care:

  • Cardio Care
  • Onco Care
  • Cardio-Metabolic Care
  • Critical Care

Primary Care:

  • Pain & Gastro Care
  • Paeds Care
  • Nutra Care
  • Gynae Care
  • Pulmo Care

Partnerships

ICI Pakistan Limited (“ICI Pakistan”) and AstraZeneca UK Limited (“AstraZeneca”) confirmed the renewal of their longstanding relationship in the cardiovascular and oncology segment. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.